Abstract:Recently, abnormal expression of interleukin-32 (IL-32) has been involved in various inflammatory or autoimmune diseases, but the level of IL-32 expression in Graves' disease (GD) is still unknown. This study is aimed to explore the human IL-32 expression in GD and the association of IL-32 expression with the disease activity of GD. A total of 125 GD patients and 97 normal controls (NC) were recruited in this study. We examined IL-32 mRNA level in peripheral blood mononuclear cells (PBMCs) of 43 GD patients and 41 controls using real-time polymerase chain reaction (RT-PCR). Serum IL-32 level of 40 GD patients and 34 controls was measured by enzyme linked immunosorbent assay (ELISA). In another cohort including 42 GD patients and 22 controls, we detected the percentages of IL-32 alpha(+) cells, CD4(+)IL-32 alpha T+ cells, and CD4(-)IL-32 alpha(+) cells in PBMCs by flow cytometry. In GD patients, IL-32 mRNA expression was dramatically higher than that in controls (P < 0.001) and positively associated with FT3 (P = 0.036, r = 0.321). Subgroup analysis revealed that IL-32 mRNA level was elevated in both newly onset GD and refractory GD group (P < 0.01, P < 0.001, respectively) compared with controls. Furthermore, in refractory GD group, the IL-32 mRNA expression also positively correlated with FT3 (P = 0.019, r = 0.560). In addition, serum IL-32 level was notably higher in GD patients than that of controls (P < 0.01). Subgroup analysis also indicated that serum IL-32 level in both newly onset GD and refractory GD group was higher in comparison with controls (P = 0.015, P = 0.023, respectively) and serum IL-32 level in refractory GD patients positively correlated with TRAb (P = 0.043, r = 0.481). The percentages of IL-32 alpha(+) cells, CD4(+)IL-32 alpha T+ cells, and CD4(-)IL-32 alpha(+) cells were all significantly enhanced in GD patients compared with controls (P = 0.005, P = 0.017, P = 0.016, respectively). IL-32 and IL-32 alpha(+) cells may be associated with the pathogenesis of GD. IL-32 may become a promising target for the treatment of GD.

Interferon-γ Up-Regulates Expressions of Indoleamine 2,3-Dioxygenase and Tryptophanyl-Trna-synthetase in Human Thyrocytes

Increased TTS abrogates IDO-mediated CD4 + T cells suppression in patients with Graves’ disease

Interleukine-6 Inhibits Sodium Iodide Symporter Gene Expression in Cultured Human Thyrocytes

Impairment of Regulatory Capacity of Cd4(+)Cd25(+) Regulatory T Cells Mediated by Dendritic Cell Polarization and Hyperthyroidism in Graves' Disease

Expression of IFNα-inducible Genes and Modulation of HLA-DR and Thyroid Stimulating Hormone Receptors in Graves’ Disease

Effect of Iodide on Gene Expression of Interleukin-6, Interferon-γ and Tumor Necrosis Factor-a in Cultured Human Thyroid Cells

Plasmacytoid dendritic cells,interferon-α and CD4~+ CD25~+ regulatory T cells in immunopathogenic mechanism of Graves disease

MiR-363-5p modulates regulatory T cells through STAT4-HSPB1-Notch1 axis and is associated with the immunological abnormality in Graves' disease

Thyrocyte Interleukin‐18 Expression is Up‐regulated by Interferon‐γ and May Contribute to Thyroid Destruction in Hashimoto’s Thyroiditis

Thyrocytes Contribute to Their Own Demise: the Role of Interleukin-18 in Hashimoto's Thyroiditis

Increased Human Interleukin-32 Expression is Related to Disease Activity of Graves' Disease.

A Protective Role of IFN-γ in T Cell-Mediated Colitis by Regulation of Treg/Th17 Via Induction of Indoleamine-2,3-deoxygenase

Serum interferon levels associated with the disease activity in women with overt Graves' disease

Osteopontin Inhibits Interferon-Γ-induced Expression of Chemokine in Thycocytes

Indoleamine 2,3-Dioxygenase Immune Status as a Potential Biomarker of Radioiodine Efficacy for Advanced Distant Metastatic Differentiated Thyroid Cancer

Increased expressions of IL-6 and its receptor gp130 in the thyroid tissues of patients with Graves' disease

The Change of CD4+CD25+Foxp3+regulatory T Cells in Peripheral Blood of Patients with Graves Disease Treated by Iodine-131

Elevated Interleukin-36α and CD4+IL-36α+T Cells Are Involved in the Pathogenesis of Graves' Disease.

Increased interleukin-9 and Th9 cells in patients with refractory Graves’ disease and interleukin-9 polymorphisms are associated with autoimmune thyroid diseases

Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects

Suppression of iodide uptake and thyroid hormone synthesis with stimulation of the type I interferon system by double-stranded ribonucleic acid in cultured human thyroid follicles